Supported by advertising from Regeneron Pharmaceuticals and Carl Zeiss Meditec
July/August 2016 Insert
AMD Disease Education Resource Center: Efficacy and Tolerability of Intravitreal Aflibercept in Patients With Exudative AMD Previously Treated With Ranibizumab or Bevacizumab
